Symtomax CBD ORAL TAB: innovative delivery for cannabinoids

Over the past few years the global market for cannabidiol (CBD) has expanded rapidly with growing demand for CBD products expected to continue through 2022 transforming this market into a mega industry of its own. According to the latest research by the Global Wellness Institute (GWI), the worldwide wellness market grew 12.9% from a $3.72 […]

Continue reading

SYMTOMAX’S PARTNER GREATER CANNABIS CEO INTERVIEWED ON YAHOO FINANCE

Symtomax’s partner the Greater Cannabis Company CEO was interviewed on Yahoo Finance today. With growing concern over vaping-related illnesses and the increase in the hundreds of patients experiencing lung ailments, Symtomax’s partnership , gives them exclusive rights to use their tested patented delivery products & distribution throughout Europe, Middle East and Africa, offering a safe […]

Continue reading